Medical devices, healthcare technology and the business of care
510(k) clearance · K253856

Geniant Cranial (Navigated Neurosurgical Positioning Robot)

Koh Young Technology, Inc. · Decision date Sep 10, 2026

MEDTECHLEDGER EXPLANATIONK253856

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 10, 2026 for K253856, Geniant Cranial (Navigated Neurosurgical Positioning Robot), submitted by Koh Young Technology, Inc. The submission is a traditional 510(k) under 21 CFR 882.4560, product code HAW, in the Neurology panel; the public database lists receipt on December 3, 2025, while the clearance letter cites June 12, 2026 dates. SESE is a clearance to market, not a PMA approval.

The cleared item is the Geniant Cranial software version V3.2, described as a hardware platform supporting real-time surgical navigation from preoperatively acquired CT or MR images, with a console and optical sensor plus a robot stand with robotic arm and patient positioning module. The 510(k) summary names the prior Geniant Cranial clearance K241333 as predicate and states that other system functions, intended use and safety features are unchanged. The summary does not specify which software changes were made, so the technical scope of the modification remains unknown from these excerpts.

The indications describe aid in locating anatomical structures and positioning instrument holders or tool guides for neurosurgeons in open or percutaneous procedures where stereotactic surgery is appropriate and a rigid structure such as the skull can be referenced to images. The summary also lists a secondary classification, neurosurgical skull clamp (882.4460, HBL). No clinical performance data are reported in the available excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Sep 10, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K253856
Regulatory pathway
510(k) premarket notification
Product code
HAW
Decision code
SESE
Decision date
Sep 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Neurological Stereotaxic Instrument.

Product code
HAW
FDA device class
2

FDA decision timeline

  1. K253856 received

    Application receipt date recorded by FDA.

  2. K253856 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HAW

Product / regulatory recordCompanyPathwayDecision dateSource
inomed Medizintechnik GmbH510(k) clearanceNov 6, 2026FDA
Medtronic Navigation510(k) clearanceNov 6, 2026FDA
NeuroAlignK261997
Medivis, Inc.510(k) clearanceOct 26, 2026FDA
Guangzhou Aimooe Technology Co., Ltd.510(k) clearanceOct 15, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Koh Young Technology, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Yeoju

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records